Oral loading with propafenone: A placebo-controlled study in elderly and nonelderly patients with recent onset atrial fibrillation

被引:18
|
作者
Boriani, G
Biffi, M
Capucci, A
Botto, GL
Broffoni, T
Rubino, I
Della Casa, S
Sanguinetti, M
Branzi, A
Magnani, B
机构
[1] Univ Bologna, Inst Cardiol, I-40138 Bologna, Italy
[2] Osped Civile, Dept Cardiol, Lugo, Spain
[3] Osped S Anna, Dept Cardiol, Como, Italy
来源
关键词
antiarrhythmic drugs; atrial fibrillation; conversion; Holter monitoring;
D O I
10.1111/j.1540-8159.1998.tb01202.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The efficacy and safety of propafenone as an oral loading dose (600-mg single oral dose) in converting recent-onset atrial fibrillation (less than or equal to 7 days duration) to sinus rhythm were evaluated in a single-blind, placebo-controlled study according to patients' age. Overall, 240 hospitalized patients, NYHA Class less than or equal to 2 without signs or symptoms of heart failure were enrolled: among patients aged less than or equal to 60 years, 55 were allocated to propafenone treatment and 59 to placebo, respectively, and among patients aged > 60 years, 64 were allocated to propafenone treatment and 62 to placebo, respectively. Results: In each age group, the likelihood of conversion to sinus rhythm was significantly greater after propafenone compared with placebo at 3 and 8 hours. For patients aged less than or equal to 60 years, corresponding odd ratios were 3.78 (95% CI = 1.80-7.92, P = 0.04) at 3 hours and 4.74 (95% CI = 2.22-10.54, P = 0.02) at 8 hours; for patients aged > 60 years odd ratios were 5.03 (95% CI = 2.08-12.12, P = 0.02) at 3 hours and 6.75 (95% CI = 3.28-73.86, P = 0.01) at 8 hours, respectively. Logistic regression analysis showed that conversion to sinus rhythm within 3 hours was predicted by age less than or equal to 60 years IP = 0.0064) and by propafenone treatment IP ( 0.0001), and conversion to sinus rhythm within 8 hours was predicted by age less than or equal to 60 years(P = 0.0467) and by propafenone treatment (P ( 0.0001). The occurrence of adverse effects was observed in 14%-16% of propafenone treated patients and in 8% of placebo treated patients without significant differences according to age. In conclusion, in patients with recent-onset atrial fibrillation without signs of heart failure, propafenone as a single oral loading dose is effective. It is also effective in selected elderly subjects with a favorable safety profile. Moreover, spontaneous conversion to sin us rhythm appears to occur less frequently in elderly patients.
引用
收藏
页码:2465 / 2469
页数:5
相关论文
共 50 条
  • [41] Comparative efficacy of intravenous propafenone and procainamide in patients with paroxysmal atrial fibrillation: Randomized placebo controlled blind study
    Kanorsky, SG
    Skibitsky, VV
    KARDIOLOGIYA, 1998, 38 (09) : 42 - 46
  • [42] Oral Loading with Propafenone for Conversion of Recent-Onset Atrial FibrillationA Review on In-Hospital Treatment
    Giuseppe Boriani
    Cristian Martignani
    Mauro Biffi
    Alessandro Capucci
    Angelo Branzi
    Drugs, 2002, 62 : 415 - 423
  • [43] Effects of digoxin on electrocardiogram in patients with acute atrial fibrillation - A randomized, placebo-controlled study
    Hornestam, B
    Held, P
    Edvardsson, N
    CLINICAL CARDIOLOGY, 1999, 22 (02) : 96 - 102
  • [44] Reproducible efficacy of loading oral propafenone in restoring sinus rhythm in patients with paroxysmal atrial fibrillation
    Capucci, A
    Villani, GQ
    Piepoli, MF
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (11): : 1345 - 1347
  • [45] A RANDOMIZED STUDY COMPARING DIGOXIN AND PROPAFENONE IN THE TREATMENT OF RECENT-ONSET ATRIAL-FIBRILLATION
    BAROFFIO, R
    TISI, G
    GUZZINI, F
    MILVIO, E
    ANNONI, P
    CLINICAL DRUG INVESTIGATION, 1995, 9 (05) : 277 - 283
  • [46] Procainamide, propafenone, amiodarone: A comparative study of their efficacy and safety for the conversion of recent onset atrial fibrillation
    Igoumenidis, NE
    Kochiadakis, GE
    Hamilos, MI
    Marketou, ME
    Klapsinos, NC
    Skalidis, EI
    Vardas, PE
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 10A - 10A
  • [47] Intravenous propafenone in paroxysmal atrial fibrillation: A randomized, placebo-controlled, double-blind, multicenter clinical trial
    Fresco, C
    Proclemer, A
    Pavan, A
    Bula, G
    Vicentini, A
    Pavan, D
    Morgera, T
    CLINICAL CARDIOLOGY, 1996, 19 (05) : 409 - 412
  • [48] Flecainide or Propafenone vs Vernakalant for Conversion of Recent-Onset Atrial Fibrillation
    Conde, Diego
    Costabel, Juan Pablo
    Aragon, Martin
    Caro, Milagros
    Ferro, Alejandra
    Klein, Andres
    Trivi, Marcelo
    Giniger, Alberto
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10)
  • [49] Clinical pattern and complications of nonvalvular atrial fibrillation in elderly and nonelderly patients
    Boriani, G
    Gallina, M
    Biffi, M
    Bronzetti, G
    Manetti, R
    De Simone, N
    Branzi, A
    Magnani, B
    JOURNAL OF CARDIOVASCULAR DIAGNOSIS AND PROCEDURES, 1998, 15 (01): : 31 - 36
  • [50] EFFECTIVENESS OF INTRAVENOUS PROPAFENONE FOR CONVERSION OF ATRIAL-FIBRILLATION AND FLUTTER OF RECENT ONSET
    BIANCONI, L
    BOCCADAMO, R
    PAPPALARDO, A
    GENTILI, C
    PISTOLESE, M
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 64 (05): : 335 - 338